Senti Biosciences, Inc. (SNTI) vs Valion Bio, Inc. (VBIO)
A side-by-side comparison of Senti Biosciences, Inc. and Valion Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SNTI
Senti Biosciences, Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
VBIO
Valion Bio, Inc.
$2.38HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT
Total return — SNTI vs VBIO
growth of $100 · dividends reinvested · last 5ySNTI -99.7% (-67.8%/yr)VBIO -100.0% (-89.8%/yr)SNTI compounded faster over this window
Log scale — wide-divergence pair
SNTI VBIO
SNTI vs VBIO: by the numbers
- •SNTI is the larger company ($10M vs $10M market cap).
- •Both run net losses; VBIO's is the smaller (0.00% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | SNTI | VBIO |
|---|---|---|
| P/S ratio | 182.06 | N/A |
| P/B ratio | N/A | 2.32 |
Profitability
| Metric | SNTI | VBIO |
|---|---|---|
| Gross margin | -16431.82% | 0.00% |
| Operating margin | -289668.18% | 0.00% |
| Net margin | -90116.36% | 0.00% |
| ROE | N/A | -157.76% |
| ROIC | -227.67% | -55.13% |
Growth (annualized)
| Metric | SNTI | VBIO |
|---|---|---|
| Revenue CAGR (5Y) | -43.85% | N/A |
| Total return CAGR (5Y) | -67.75% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.